Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates
Portfolio Pulse from
Charles River Laboratories (CRL) reported Q4 earnings of $2.66 per share, surpassing the Zacks Consensus Estimate of $2.50. This marks an increase from $2.46 per share a year ago.
February 19, 2025 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Charles River Laboratories reported Q4 earnings of $2.66 per share, exceeding expectations and showing growth from the previous year.
CRL's earnings per share exceeded analyst expectations and showed year-over-year growth, which is typically viewed positively by investors and could lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100